Skip to main content
editorial
. 2020 Dec 31;99(3):524–527. doi: 10.1016/j.kint.2020.12.021

Figure 1.

Figure 1

Proposed approach for the provision of renal replacement therapy (RRT) and modality selection in Latin America during coronavirus disease 2019 (COVID-19) pandemic. Overview of a stepwise approach for providing RRT to patients with COVID-19; in hemodynamically unstable patients, continuous renal replacement therapy (CRRT) is the therapy of choice if available, and prolonged intermittent renal replacement therapy (PIRRT) and peritoneal dialysis (PD) can be used if CRRT is not available. In hemodynamically stable patients, intermittent hemodialysis (IHD) and PD can be used. Selection should be based on local equipment availability, supplies, and local expertise. APD, automated peritoneal dialysis; AKI, acute kidney injury; CVVH, continuous veno-venous hemofiltration; CVVHD, continuous veno-venous hemodialysis; CVVHDF, continuous veno-venous hemodiafiltration; Qb, blood flow rate; Qd, dialysis fluid flow rate; SCUF, slow continuous ultrafiltration; UF, ultrafiltration; UFnet, net ultrafiltration.